F Kolbinger
Overview
Explore the profile of F Kolbinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaul M, Jarvis P, Rozenberg I, Kolbinger F, Di Padova F, Calonder C, et al.
J Eur Acad Dermatol Venereol
. 2021 Feb;
35(5):1143-1151.
PMID: 33617042
Background And Objective: Anti-IL-17A IgG/κ monoclonal antibody CJM112 binds both IL-17A and IL-17AF. The purpose of this First-in-Human study was to assess CJM112 effects on safety and efficacy in patients...
2.
Reich K, Blauvelt A, Armstrong A, Langley R, de Vera A, Kolbinger F, et al.
J Eur Acad Dermatol Venereol
. 2019 Apr;
33(9):1733-1741.
PMID: 31009130
Background: Secukinumab is a fully human monoclonal antibody that selectively neutralizes IL-17A, a key cytokine involved in psoriasis and psoriatic arthritis development, and has shown rapid and long-lasting efficacy and...
3.
Accart N, Dawson J, Kolbinger F, Kramer I, Beckmann N
Eur J Histochem
. 2017 Jan;
60(4):2667.
PMID: 28076929
Ankylosing spondylitis is a common rheumatic disease involving both inflammatory erosive osteopenia and bony overgrowth. Main disease features are recapitulated in small rodents challenged with complete Freund's adjuvant. MRI was...
4.
Holland S, Liao X, Mendenhall M, Zhou X, Pardo J, Chu P, et al.
J Exp Med
. 2001 Nov;
194(9):1263-76.
PMID: 11696592
In an effort to identify novel therapeutic targets for autoimmunity and transplant rejection, we developed and performed a large-scale retroviral-based functional screen to select for proteins that inhibit antigen receptor-mediated...
5.
Bonfoco E, Li E, Kolbinger F, Cooper N
J Biol Chem
. 2001 May;
276(31):29242-50.
PMID: 11350957
Caspases play important roles in regulating apoptotic signaling pathways. Here we report the cloning, by the yeast two hybrid system with dominant negative caspase-2 as "bait," of a proapoptotic molecule...
6.
Norman K, Katopodis A, Thoma G, Kolbinger F, HICKS A, Cotter M, et al.
Blood
. 2000 Nov;
96(10):3585-91.
PMID: 11071658
Selectin-dependent rolling is the earliest observable event in the recruitment of leukocytes to inflamed tissues. Several glycoproteins decorated with sialic acid, fucose, and/or sulfate have been shown to bind the...
7.
Baisch G, Ohrlein R, Kolbinger F, Streiff M
Bioorg Med Chem Lett
. 1999 Jan;
8(12):1575-8.
PMID: 9873393
A series of non-natural N-acyl derivatives of lactosamine is incubated with recombinant alpha(1-3)galactosyl-transferase and UDP-galactose. The enzyme shows a high promiscuity towards the non-natural acceptors. It selectively transfers a galactose...
8.
Baisch G, Ohrlein R, Streiff M, Kolbinger F
Bioorg Med Chem Lett
. 1999 Jan;
8(7):755-8.
PMID: 9871536
A series of sialylated type-I sugars, which have the natural N-acetyl group of the glucosamine moiety replaced by a wide range of amides, is incubated with recombinant fucosyl-transferase III and...
9.
Baisch G, Ohrlein R, Streiff M, Kolbinger F
Bioorg Med Chem Lett
. 1999 Jan;
8(7):751-4.
PMID: 9871535
A number of non-natural N-acyl derivatives of glucosamine is incubated with a recombinant beta(1-3)galactosyl-transferase and UDP-galactose. Surprisingly, the enzyme recognizes the non-natural acceptors as substrates and transfers galactose onto the...
10.
Fritz J, Katopodis A, Kolbinger F, Anselmetti D
Proc Natl Acad Sci U S A
. 1998 Oct;
95(21):12283-8.
PMID: 9770478
Leukocytes roll along the endothelium of postcapillary venules in response to inflammatory signals. Rolling under the hydrodynamic drag forces of blood flow is mediated by the interaction between selectins and...